Haploidentical stem cell transplantation with purified CD34+ cells after a chemotherapy-alone conditioning regimen

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 10, 2003, Pages 633-642

  Lacerda, Jõao F ^a   Martins, C ^a   Carmo, J A ^a   Lourenco F ^a   Juncal, C ^a   Rodrigues, A ^a   Vilalobos, I ^a   Moura, M C ^a   Ligeiro, D ^b   Martinho, A ^c   Lacerda, J M F ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b Ministerio da Saude Portuguese   (Portugal)

^c Histocompatibility Centre   (Portugal)

Author keywords

Chemotherapy alone conditioning regimen; Haploidentical stem cell transplantation; Hematologic malignancies; Purified CD34+ cells

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN A; FLUDARABINE; FOSCARNET; GANCICLOVIR; GEMTUZUMAB OZOGAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOGLOBULIN; ITRACONAZOLE; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROSTAGLANDIN E1; STEROID; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; ANTIGEN PURIFICATION; ARTICLE; BRONCHIOLITIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CAUSE OF DEATH; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HIGH RISK PATIENT; HLA MATCHING; HUMAN; INFECTION; LEUKEMIA REMISSION; LIVER VENOOCCLUSIVE DISEASE; LYMPHOCYTE DEPLETION; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL TIME; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GRAFT SURVIVAL; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; LEUKEMIA; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 12144286211     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(03)00263-5     Document Type: Article

References (31)

1. Thomas E.D. Marrow transplantation for malignant diseases J Clin Oncol. 1 1983 517-531
2. Hansen J.A. Petersdorf E. Martin P.J. Anasetti C. Hematopoietic stem cell transplants from unrelated donors Immunol Rev. 157 1997 141-151
3. Kernan N.A. Bartsch G. Ash R.C. et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program N Engl J Med. 328 1993 593-602
4. Beatty P.G. Mori M. Milford E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor Transplantation. 60 1995 778-783
5. Reisner Y. Kapoor N. Kirkpatrick D. et al. Transplantation for severe combined immunodeficiency with HLA-A, B, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood. 61 1983 341-348
6. Henslee-Downey P.J. Abhyankar S.H. Parrish R.S. et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant Blood. 89 1987 3864-3872
7. Aversa F. Tabilio A. Terenzi A. et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood. 84 1994 3948-3955
8. Aversa F. Tabilio A. Velardi A. et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype N Engl J Med. 339 1998 1186-1193
9. Guinan E.C. Boussiotis V.A. Neuberg D. et al. Transplantation of anergic histoincompatible bone marrow allografts N Engl J Med. 340 1999 1704-1714
10. + progenitor cells from HLA-mismatched parental donors in children Bone Marrow Transplant. 27 2001 777-783
11. Reisner Y. Martelli M. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells Immunol Today. 16 1995 437-440
12. Lacerda J.F. Ladanyi M. Louie D.C. Fernandez J.M. Papadopoulos E. O'Reilly R.J. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced lymphoproliferations in xenografted C. B-17 scid/scid mice J Exp Med. 183 1996 1215-1228
13. Antin J.H. Childs R. Filipovich A.H. et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation Biol Blood Marrow Transplant. 7 2001 473-485
14. Vogelsang G.B. Hess A.D. Santos G.W. Acute graft-versus-host disease: clinical characteristics in the cyclosporine era Medicine. 67 1988 163-174
15. Akpek G. Zahurak M.L. Piantadosi S. et al. Development of a prognostic model for grading chronic graft-versus-host disease Blood. 97 2001 1219-1226
16. Kaplan E.L. Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc. 53 1958 457-481
17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep. 50 1966 163-170
18. Simon R. A decade of progress in statistical methodology for clinical trials Stat Med. 10 1991 1789-1817
19. Ruggeri L. Capanni M. Casucci M. et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood. 94 1999 333-339
20. Ruggeri L. Capanni M. Urbani E. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science. 295 2002 2097-2100
21. Aristei C. Latini P. Faicinelli F. Latini R.A. Aversa F. The role of total body irradiation in the conditioning of patients receiving haploidentical stem cell transplantation Tumori. 87 2001 402-406
22. Small T.N. Papadopoulos E.B. Boulad F. et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions Blood. 93 1999 467-480
23. Papadopoulos E.B. Ladanyi M. Emanuel D. et al. Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation N Engl J Med. 330 1994 1185-1191
24. O'Reilly R.J. Lacerda J.F. Lucas K.G. Rosenfield N.S. Small T.N. Papadopoulos E.B. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants In de Vita V.T. Jr Hellman S. Rosenberg S. (Eds.), Important Advances in Oncology 1996 1996 149-166 Lippincott-Raven Philadelphia
25. Champlin R. Hesdorffer C. Lowenberg B. et al. Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings Leukemia. 16 2002 427-428
26. Volpi I. Perruccio K. Tosti A. et al. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants Blood. 97 2001 2514-2521
27. Blazar B.R. Widmer M.B. Cosman D. Sassenfeld H.M. Vallera D.A. Improved survival and leukocyte reconstitution without detrimental effects on engraftment in murine recipients of human recombinant granulocyte colony-stimulating factor after transplantation of T-cell-depleted histoincompatible bone marrow Blood. 74 1989 2264-2269
28. + cells Blood. 99 2002 4171-4181
29. Handgretinger R. Lang M. Schumm M. et al. Immunological aspects of haploidentical stem cell transplantation in children Ann N Y Acad Sci. 872 1999 340-358
30. Riddell S.R. Watanabe R.S. Goodrich J.M. Li C.R. Agha M.E. Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones Science. 257 1992 238-242
31. Lacerda J.F. Carmo J.A. Martins C. et al. Durable donor engraftment in haplo-identical stem cell transplantation with standard dose purified CD34+ cells after a chemotherapy alone conditioning regimen Blood. 98 2001 478 (abstr.)